ProMIS Neurosciences Inc PMN

Funding boost expands MND research in our region (Australia)

[BottomBroker]

Using PMN technology...

https://www.miragenews.com/funding-boost-expands-mnd-research-in-our-region-645228/

Three researchers from the Illawarra Health and Medical Research Institute (IHMRI) and the University of Wollongong (UOW) have received a share of $1.5 million from FightMND to investigate potential treatments for motor neurone disease (MND).

MND is a terminal neurodegenerative disease with no current cure or effective treatment options. The rapidly progressive disease causes motor neurones, the pathways between the brain and muscles, to degenerate and die. As a result, MND leaves patients with the inability to walk, talk and eventually breathe.

Professor Justin Yerbury has been awarded a Drug Development Grant for nearly $1million for the second year running. His latest research project will test a gene therapy in collaboration with ProMIS Neurosciences that targets misfolded proteins associated with familial MND.

[DavidKingCanada]

Great find BB! 

[retiredcop]

The most common type of MND, amyotrophic lateral sclerosis (ALS), probably affects up to 30,000Americans at any given time, with over 5,600 diagnoses each year, according to the ALS Association.

[retiredcop]

Now to figure out which science they are using from PMN..probabaly have to figure it out becuase PMN does not seem to want to acknowledge things like this    TDP-43, ALS FTD, LATE   SOD1 ALS   RACK1 ALS HD, cancers Immunizations   Ataxin2 ALS   Disc1 ALS Schizophrenia

[M101]

Why would it matter which? It's all validation of the platform. And it would be tough to tout this sort of research before results credit the technology, it's a plus but there's no money associated so the market would blow it off as desperation for news.    

[JackRedwood]

Along side PMN310 ProMIS has two other lead products that could potentially treat Alzheimer’s disease, PMN330 and PMN350, which target different areas on toxic amyloid beta aggregates.

[retiredcop]

One of the Australian researchers could have a stronger desire than most to get this to clinicals .... Justin John Yerbury AM (born 1974) is an Australian molecular biologist who was spurred to follow a career in biological research when he discovered his family has the genetic form of motor neuron disease (MND). He holds the position of Professor in

[retiredcop]

https://www.miragenews.com/funding-boost-expands-mnd-research-in-our-region-645228/ From this link that bottom broker provided, it appears this research is related to SOD1. Dr Cashman has spent over 20 years working and researching SOD1 as it relates to ALS. HE is also convinced that SOD1 is the main culprit.